News
1d
MarketBeat on MSNUnitedHealth Stock Dips: Is This a Value Buy Opportunity?CompanyOverview|NYSE:UNH] UnitedHealth Group (NYSE: UNH) is a dominant force within the healthcare sector, a critical ...
The incidence and prevalence of CTD-ILD in the US is most common among women and older individuals, affecting approximately ...
Baird has lowered its rating on UnitedHealth, moving from "Outperform" to "Neutral" thanks to a gnarly Medicare model shift.
2d
Barchart on MSNUnitedHealth Stock Just Raised Its Dividend. Should You Buy UNH Now?UnitedHealth Group (UNH) is back in the spotlight with a new dividend increase, bumping its quarterly payout from $2.10 to $2.21 per share. UnitedHealth’s annual dividend now totals $8.84 per share, ...
Allegations against UnitedHealth Group (NYSE: UNH) that it secretly paid nursing homes in order to reduce hospital transfers ...
The UnitedHealth Group division is taking Johnson & Johnson's Stelara — one of the most popular, best-known and most expensive "biologic" anti-inflammatory drugs — off the standard formulary for many ...
Kotek told reporters at a news conference Monday that the bill should be a model for other states and for Congress.
Delving into the details, we found 30% of traders were bullish, while 65% showed bearish tendencies. Out of all the trades we ...
More bad news came in 2025. UnitedHealth Group reported lower-than-expected first-quarter earnings in April. The company ...
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price ...
US insurance behemoth UnitedHealth Group is suing The Guardian for defamation weeks after the British-based newspaper ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results